Oncternal Therapeutics Inc (ONCT)
US68236P2065 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.315M 27.85% | 1.49M -65.47% | 785K -47.32% | 1.678M 113.76% | 612K -63.53% | 1.02M 66.67% | 765K -25.00% | 765K | -100.00% | ||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -31.366M -78.81% | -44.947M -43.30% | -41.714M 7.19% | -37.436M 10.26% | -50.388M -34.60% | -58.14M -15.38% | -65.535M -12.72% | -65.535M | -15.559M 76.26% | -6.34M 59.25% | |
| Operating Margin | -726.91% | -3,016.58% | -5,313.89% | -2,230.99% | -8,233.33% | -5,700.00% | -8,566.67% | -8,566.67% | N/A | N/A | |
| EPS YoY % growth | -12.60 37.61% | -16.80 -33.33% | -13.51 19.58% | -12.12 10.27% | -10.46 13.76% | -6.28 39.90% | -5.46 13.15% | -5.34 2.06% | 0.74 113.93% | 1.81 142.47% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -3.02 2.92% | -2.47 12.78% | -2.23 22.71% | -2.04 28.67% | -2.09 30.74% |
| Revenue Q2Q % growth | 140.25K -52.78% | 204K -64.15% | 204K -74.53% | 204K -58.70% | 204K 45.45% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.343M 3.04% | -11.166M -27.19% | -11.47M -29.41% | -11.73M -35.12% | -12.101M -29.52% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -2.86 15.88% | -3.26 | 0.40 | 12.24% |
| Q2 2024 Q2Q % growth | -2.89 3.67% | -3.17 | 0.28 | 8.75% |
| Q1 2024 Q2Q % growth | -2.83 29.25% | -2.94 | 0.11 | 3.58% |
| Q4 2023 Q2Q % growth | -3.11 22.25% | -3.13 | 0.02 | 0.60% |
| Q3 2023 Q2Q % growth | -3.40 19.05% | -2.96 | -0.44 | -14.94% |
| Q2 2023 Q2Q % growth | -3.00 34.78% | -3.26 | 0.26 | 8.09% |
| Q1 2023 Q2Q % growth | -4.00 | -4.15 | 0.15 | 3.57% |
| Q4 2022 Q2Q % growth | -4.00 -25.00% | -4.25 | 0.25 | 5.88% |
| Q3 2022 Q2Q % growth | -4.20 -10.53% | -4.83 | 0.63 | 13.01% |
| Q2 2022 Q2Q % growth | -4.60 -43.75% | -4.66 | 0.06 | 1.24% |
| Q1 2022 Q2Q % growth | -4.00 -66.67% | -4.13 | 0.13 | 3.17% |
| Q4 2021 Q2Q % growth | -3.20 -77.78% | -5.02 | 1.82 | 36.23% |
| Q3 2021 Q2Q % growth | -3.80 13.64% | -3.26 | -0.54 | -16.42% |
| Q2 2021 Q2Q % growth | -3.20 | -2.81 | -0.40 | -14.08% |
| Q1 2021 Q2Q % growth | -2.40 | -2.04 | -0.36 | -17.65% |
| Q4 2020 Q2Q % growth | -1.80 | -3.67 | 1.87 | 50.98% |
| Q3 2020 Q2Q % growth | -4.40 | -6.12 | 1.72 | 28.10% |
| Q4 2018 Q2Q % growth | -4.40 | -4.39 | -0.01 | -0.32% |
| Q3 2018 Q2Q % growth | -7.80 | -6.12 | -1.68 | -27.45% |
| Q2 2018 Q2Q % growth | -8.60 | -8.77 | 0.17 | 1.96% |
| Q1 2018 Q2Q % growth | -12.40 | -8.77 | -3.63 | -41.36% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 494K 175.98% | 140.25K | 353.75K | 252.23% |
| Q2 2024 Q2Q % growth | 801K 655.66% | 242.25K | 558.75K | 230.65% |
| Q1 2024 Q2Q % growth | 569K 180.30% | 180.203K | 388.797K | 215.75% |
| Q4 2023 Q2Q % growth | 297K 73.68% | 140.25K | 156.75K | 111.76% |
| Q3 2023 Q2Q % growth | 179K -53.14% | 127.5K | 51.5K | 40.39% |
| Q2 2023 Q2Q % growth | 106K -44.50% | 209.1K | -103.1K | -49.31% |
| Q1 2023 Q2Q % growth | 203K -72.79% | 170.003K | 32.997K | 19.41% |
| Q4 2022 Q2Q % growth | 171K -69.24% | 338.13K | -167.13K | -49.43% |
| Q3 2022 Q2Q % growth | 382K -82.05% | 311.916K | 70.084K | 22.47% |
| Q2 2022 Q2Q % growth | 191K -78.37% | 468.18K | -277.18K | -59.20% |
| Q1 2022 Q2Q % growth | 746K -0.27% | 535.5K | 210.5K | 39.31% |
| Q4 2021 Q2Q % growth | 556K -64.99% | 1.555M | -999K | -64.24% |
| Q3 2021 Q2Q % growth | 2.128M 263.76% | 1.324M | 804K | 60.73% |
| Q2 2021 Q2Q % growth | 883K 41.73% | 1.111M | -228K | -20.52% |
| Q1 2021 Q2Q % growth | 748K 29.41% | 1.137M | -389K | -34.21% |
| Q4 2020 Q2Q % growth | 1.588M 115.76% | 599.25K | 988.75K | 165.00% |
| Q3 2020 Q2Q % growth | 585K 7.54% | 635.46K | -50.46K | -7.94% |
| Q2 2020 Q2Q % growth | 623K -7.57% | % | ||
| Q1 2020 Q2Q % growth | 578K 22.98% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -15.93% | 0% | -4.25% |
| Revenue | 0% | -24.31% | 0% | -2.44% |